Christopher Gasparis: Anticoagulation After Atrial Fibrillation Ablation – Long-Term Impact on Stroke
Christopher Gasparis, Surgery Resident at Northwell Health, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Heart Rhythm O2, adding:
“Excited to share our new ITHACA database publication in Heart Rhythm O2!
We investigated the long-term risk of stroke in select patients with elevated CHA2DS2-VASc score who discontinued anticoagulation following atrial fibrillation ablation.
A big thank you to my mentors Stavros Mountantonakis and Kristie Coleman and my coauthors Stefanos Zafeiropoulos, Jonas Leavitt, Elliot Wolf, Ari Zimmer, Rajat Goyal and Dr. Laurence Epstein for their guidance and contributions.”
Title: Anticoagulation Decision Based on Atrial Fibrillation Ablation Outcomes and Long-Term Impact on Stroke. An ITHACA Database Study
Authors: Christopher Gasparis, Stefanos Zafeiropoulos, Jonas Leavitt, Elliot Wolf, Ari Zimmer, Rajat Goyal, Laurence M. Epstein, Kristie M. Coleman, Stavros E. Mountantonakis.
Stay updated with Hemostasis Today.
-
Sep 19, 2026, 01:53Thomas Dayspring: Understanding Genome and Lipid Interactions in Lipidology
-
Sep 19, 2026, 01:47Abdurrahman Tufan: Combination Targeted Therapy in Refractory Systemic Autoinflammatory Diseases
-
Sep 19, 2026, 01:44Patrick James Lynch: Mother of a Thousand Sons Premieres at BDC 2026
-
Sep 19, 2026, 01:41Genetic Fate Mapping Reveals Endothelial Cells During Venous Thrombus Resolution – RPTH Journal
-
Sep 19, 2026, 01:39Mostafa Hammam: Three Different Platelet Defects – One Common Symptom
-
Sep 19, 2026, 01:38Jeff Sternlicht: A Heart Attack Should Not Be the Starting Line
-
Sep 19, 2026, 01:28Luis Oliverio Ambriz Garcia: Key Points From the ASH 2026 Guidelines on Iron Deficiency
-
Sep 19, 2026, 01:27Farjah Algahtani: A New Era in the Treatment of Transfusion-Dependent Thalassaemia
-
Sep 19, 2026, 01:24Aravind Palraj: 2025 EULAR Behçet’s Syndrome Update – 5 Practical Take-Home Points